BioSig rises on higher demand for cardiac signal device

Streamex

01/11/2021 17:00

** Shares in medical tech co BioSig Technologies  BSGM.O 
rise ~14% to $3.08
    ** Co says it has exceeded 2021 procedural target for PURE
EP System, its noise-filtering technology for ECG and
intra-cardiac signals (https://refini.tv/2ZFFzRF)
    ** Says as of Oct 21, PURE EP System had been used in over
1,560 patient cases
    ** Co raises its procedural target for 2021 and now intends
to complete between 1,700-1,800 procedures by year-end
    ** Guidance raised due to increased adoption of the
technology and continual decline in rate of COVID-19
hospitalization - BSGM
    ** Shares down ~21% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))